AMGEN <AMGN> TO FORM PARTNERSHIP
Amgen Inc said it signed a letter of intent for an estimated 75 mln dlr research and development limited partnership to fund the clinical investigation of certain pharmaceutical products currently under development.     Neither terms of the arrangement nor the products covered by the partnership were disclosed, but Amgen said the limited partnership units will include warrants to purchase Amgen common stock.
